The molecular mechanisms that regulate the formation of the lymphatic vascular system remain poorly characterized. Whereas studies in embryonic stem (ES) cells have provided major new insights into the mechanisms of blood vessel formation, development of lymphatic endothelium has not been previously observed. We established embryoid bodies (EBs) from murine ES cells, in the presence or absence of lymphangiogenic growth factors. We found that lymphatic endothelial cells develop at day 18 after EB formation. These cells express CD31 and the lymphatic lineage markers Prox-1 and Lyve-1, but not the blood vascular marker MECA-32, and frequently sprout from preexisting blood vessels. Lymphatic vessel formation was potently promoted by VEGF-A and VEGF-C, but not bFGF. Our results reveal -for the first time -that ES cells can differentiate into lymphatic endothelial cells, and identify the EB assay as powerful new tool to dissect the molecular mechanisms that control lymphatic vessel formation.
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Abstract
The molecular mechanisms that regulate the formation of the lymphatic vascular system remain poorly characterized. Whereas studies in embryonic stem (ES) cells have provided major new insights into the mechanisms of blood vessel formation, development of lymphatic endothelium has not been previously observed. We established embryoid bodies (EBs) from murine ES cells, in the presence or absence of lymphangiogenic growth factors. We found that lymphatic endothelial cells develop at day 18 after EB formation. These cells express CD31 and the lymphatic lineage markers Prox-1 and Lyve-1, but not the blood vascular marker MECA-32, and frequently sprout from preexisting blood vessels. Lymphatic vessel formation was potently promoted by VEGF-A and VEGF-C, but not bFGF. Our results reveal -for the first time -that ES cells can differentiate into lymphatic endothelial cells, and identify the EB assay as powerful new tool to dissect the molecular mechanisms that control lymphatic vessel formation.
Introduction
The lymphatic vascular system plays a pivotal role in mediating tissue fluid homeostasis and cancer metastasis but the molecular mechanisms that regulate its formation remain poorly characterized. Recent studies in mice deficient for the lymphatic-specific transcription factor Prox-1 1 have confirmed the hypothesis originally proposed by Florence Sabin more than 100 years ago that -in mammalsthe lymphatic vascular system develops by endothelial cell sprouting from embryonic veins 2, 3 . Prox-1 plays a major role in the induction of lymphatic cell fate in early lymphatic progenitors that bud off the cardinal veins 1 and in the lymphatic reprogramming of differentiated vascular endothelial cells. [4] [5] [6] Vascular endothelial growth factor (VEGF)-C is necessary for the further embryonic development of the lymphatic vascular system. 7 Although a number of additional mediators -such as angiopoietin-2 8 , neuropilin-2 9 and podoplanin 10 -have recently been shown to contribute to lymphatic vessel formation, research into the mechanisms of lymphatic vessel development has been hampered by the frequent embryonic or perinatal lethality observed in the different mutant mouse models. 7, 10, 11 Similar obstacles were encountered in the investigation of blood vessel development.
However, it has been found that embryonic stem (ES) cells can differentiate into blood vascular endothelial cells in monolayer cultures and within the threedimensional structure of ES cell-derived embryoid bodies (EBs). [12] [13] [14] Consecutively, studies in normal and mutant ES cells have provided new insights into the molecular mechanisms of blood vessel formation. In contrast, development of lymphatic endothelium has not been observed thus far in ES or EB cultures observed for up to 14 days after their formation.
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We hypothesized that -similar to normal embryonic development -a longer time period might be needed for induction of lymphatic endothelial differentiation than for blood vascular differentiation in EBs, and that formation of lymphatic endothelium might be stimulated by addition of lymphangiogenic growth factors such as VEGF-C 16 and VEGF-A 17, 18 . We established EBs from murine ES cells and investigated expression of the lymphatic lineage markers Prox-1 and LYVE-1, a hyaluronan receptor, for up to 4 weeks after initiation of EB formation, in the presence or absence of lymphangiogenic growth factors.
Materials and Methods
Cell culture and establishment of EBs
Murine R1 
Immunofluorescence and quantitative analyses of vessel development
EBs were stained using antibodies against mouse LYVE-1 (AngioBio, Del Mar, CA), 
Results and Discussion
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Development of lymphatic endothelial cells in EBs
Differential immunostains of EBs for the panvascular marker CD31 and for the lymphatic-specific transcription factor Prox1 or the lymphatic-specific hyaluronan receptor LYVE-1 revealed numerous CD31+/Prox-1-/LYVE-1-blood vascular endothelial cells at 14 days after initiation of EB formation, whereas no CD31+/Prox-1+/LYVE-1+ lymphatic endothelial cells were observed (data not shown), in agreement with previous studies. 15 Beginning at day 18, several vascular structures consisting of CD31+/Prox-1+ lymphatic endothelial cells were detected, with a typical nuclear expression of Prox-1 ( Fig. 1 A-F ; day 27). Lymphatic endothelial cells also expressed LYVE-1 ( Fig. 1 D-F) , indicating that they were budding off the primitive vascular networks followed by sprouting, similar to the early development of lymphatic progenitors during mouse embryogenesis. 23 We also
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Future time-lapse studies of ES cells that express green fluorescent protein under control of lymphatic lineage-specific promoters such as Prox-1 or LYVE-1 will be needed to further establish the detailed sequence of events during lymphatic vessel formation in EBs.
VEGF-A and VEGF-C promote lymphatic endothelial cell formation in EBs
Previously, VEGF-A, VEGF-C and bFGF have been found to induce lymphatic vessel growth in adult mice. [16] [17] [18] 24 Addition of VEGF-A or of VEGF-C at day 14 of EB development, for four days, potently promoted lymphatic vessel formation, as evaluated by the average number of and by the average area covered by lymphatic vascular structures per EB (Fig. 2 A,B) . In contrast, bFGF had no effect ( Fig. 2 A,B) whereas all factors promoted blood vessel growth (data not shown), in accordance with previous results. 15, 25 After 7 days of treatment, the effect of VEGF-C was more potent than that of VEGF-A (average lymphatic area: VEGF-C +415% versus VEGF-A +115%; average number of lymphatic vascular structures: VEGF-C +111% versus VEGF-A +42%). Future studies are needed to evaluate the relative contribution of VEGFR-2 versus VEGFR-3 to these effects.
Taken together, our results reveal -for the first time -that mouse ES cells can differentiate into lymphatic endothelial cells and that this differentiation is promoted by VEGF-A and VEGF-C. They also identify the EB assay as a simple and powerful new in vitro tool to dissect the molecular mechanisms that control lymphatic vessel formation.
For personal use only. on April 13, 2017 . by guest www.bloodjournal.org For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From
